Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout
  • USA - English


News provided by

Dr.Scabies Natural Relief

Sep 02, 2014, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Scabies®  - Treatment For Scabies
Dr. Scabies® - Treatment For Scabies

It's been 4 days since I began Dr.Scabies treatment and let me tell you this stuff is the BEST! 100% better than 20 tubes of Permethrin cream, which I've used before.

Post this

Niagara Falls, New York (PRWEB) September 02, 2014 -- “Is there an ultimate treatment for scabies?” This is the question that millions of people ask. Diagnosing and curing scabies pose a great challenge among health care providers, patients and their families or treatment partners. The diagnostic challenge it presents often lead to misdiagnosis due to its distinct similarities to other skin conditions such as: papular urticaria, canine scabies, atopic dermatitis, impetigo, bed bug bites, eczema, varicella and many others. Scabies is also highly contagious thus, in order to eradicate it completely, proper treatment of all household members should coincide with environmental control measures otherwise, it will only be an endless cycle of transmission and re-infestation.

Over the years, Dr. Scabies® has been chosen by individuals, families and homeopathic practitioners as a natural alternative for healing scabies. The unique blend of solid, experienced leadership team, credible research and development, and products that can people can believe in make Dr. Scabies® far more established. Understand why it has become the preferred natural way of curing scabies.
Individuals and families with scabies are keen to try natural alternatives for many reasons. However, one reason is certain and that is their preference to avoid harsh chemicals or pesticides in treating themselves. One of the most commonly prescribed pesticides for scabies is permethrin 5%. Prescription is needed to be able to buy it in pharmacies. Permethrin belongs to a group of drugs called pyrethrins. Pyrethrin is commonly used in industrial and agricultural settings as “pesticides.”

The intensity of health effects from permethrin will depend on how someone is exposed to it. When people get permethrin on their skin, they may have irritation or tingling, burning and itching at that spot. If permethrin accidentally gets caught in the eyes, it can cause redness, pain or burning. If people ingest permethrin it could cause sore throat, abdominal pain, nausea and vomiting. People that have breathed in permethrin have had irritation in the nose and lungs, difficulty breathing, headaches, dizziness, nausea and vomiting.

Reported cases of treatment failure using permethrin creams are on the rise. Aside from the harmful nature of this drug, incorrect prescribing, dispensing, concentration and treatment indication will lead to resistance of scabies mites to permethrin. Lack of response to treatment will worsen the condition and intensify the contagiousness of the disease.

Due to known harsh effects of permethrin and other pharmaceutical scabicides, Dr. Scabies® encourages everyone to choose healthier and safer alternative. Dr. Scabies Solutions are formulated in such a way it will not allow the scabies mites to develop resistance nor cause any changes on the body that will compromise its safety.

Dr. Scabies® flagship products – Dr. Scabies® Liquid Soap, Dr. Scabies® Concentrated Bath Solution and Dr. Scabies® Cream, have raised the efficiency standards of scabies treatment. These products are safe, time-saving, relevant and easy to use. A product is only as good as the actual results it offers. The credibility of Dr. Scabies® resonates from a number of documented cases, before and after pictures, testimonials and story after story from real people who have been helped by Dr. Scabies®. People who used Dr. Scabies® report their symptoms are relieved and quality of life restored without the side-effects often experienced with mainstream pharmaceutical scabicides.

More than growing the company, Dr. Scabies® empower their customers and intensify their awareness and health-seeking behavior with a 30-day money back guarantee. It is a sad truth that the people who grew tired and became remorseful from recurrence of scabies and usage of multiple products leaving half-empty bottles and jars in their drawers because it did not give the results they were hoping for are no longer motivated to try anything else. Most people do not have the time or money to buy multiple treatments that is why Dr. Scabies® just had to create a situation where they realistically succeed in getting healed. This makes Dr. Scabies® a rare company that trusts its products so much that they ask people to try it risk-free.
Dr. Scabies® has established global presence over the years especially in countries most vulnerable to scabies occurrence. The initiatives of Dr. Scabies® to disseminate awareness of the disease and provision of safe and effective treatment for scabies have contributed largely to the cure rate on a global scale. This important milestone has encouraged many individuals and families to be more vigilant in fighting scabies

About Dr. Scabies®

Dr. Scabies® is an all-natural brand of products that have specific formulation to achieve optimum results while establishing high margin of safety among consumers regardless of age, gender and socio-economic status. Dr. Scabies® only uses plant-based and naturally-derived ingredients that have high-grade quality and compliant with Food and Drug Administration (FDA) and Homeopathic Pharmacopoiea of the United States (HPUS) compendium so it is safe for personal daily treatment and environment. Dr. Scabies® pride itself as consumer-friendly brand for its experience in managing and treating scabies, proven systems, and all out support in providing safe and sound treatment advice.

Paulina S., Dr.Scabies Natural Relief, http://www.drscabies.com, +1 8447222437, [email protected]

Modal title

Dr. Scabies®  - Treatment For Scabies - Leaflet
View PDF
Dr. Scabies® - Treatment For Scabies - Leaflet
Dr. Scabies®  - Treatment For Scabies - Leaflet
View PDF
Dr. Scabies® - Treatment For Scabies - Leaflet
Dr. Scabies®  - Treatment For Scabies - Leaflet Dr. Scabies®  - Treatment For Scabies - Leaflet

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.